img

Global Diabetes Drug Therapy Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Diabetes Drug Therapy Market Research Report 2024

Diabetes is group of metabolic disorder, often referred as diabetes mellitus, results in high blood glucose levels. Body cells use glucose as a source of energy and insulin is important for the cells to absorb this glucose. When the body cells loose the capacity to respond to the insulin or body is not capable of producing sufficient insulin, it leads to an increase in blood glucose levels in the body. This condition is referred to as diabetes. Depending on the cause of development, it is divided into three types, which includes type 1 diabetes (body loses the capacity of producing sufficient insulin), type 2 diabetes (most common and body cells do not respond to insulin) and gestational diabetes (occurs in pregnant women). Among these, type 2 diabetes is the most common type and affects over 90% of the global diabetic patients.
According to Mr Accuracy reports’s new survey, global Diabetes Drug Therapy market is projected to reach US$ 19490 million in 2034, increasing from US$ 9700 million in 2024, with the CAGR of 10.0% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Diabetes Drug Therapy market research.
Key companies engaged in the Diabetes Drug Therapy industry include Abbott Laboratories, Mannkind Corporation, Bristol Myers Squibb, Medtronic, AstraZeneca, Eli Lilly and Company, GlaxoSmithKline, Sanofi and Novo Nordisk, etc. Among those companies, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % value of Diabetes Drug Therapy were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Diabetes Drug Therapy market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Diabetes Drug Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Abbott Laboratories
Mannkind Corporation
Bristol Myers Squibb
Medtronic
AstraZeneca
Eli Lilly and Company
GlaxoSmithKline
Sanofi
Novo Nordisk
Novartis International AG
Segment by Type
Oral
Subcutaneous
Intravenous

Segment by Application


Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Diabetes Drug Therapy report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Drug Therapy Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Oral
1.2.3 Subcutaneous
1.2.4 Intravenous
1.3 Market by Application
1.3.1 Global Diabetes Drug Therapy Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Online Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Retail Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Drug Therapy Market Perspective (2018-2034)
2.2 Diabetes Drug Therapy Growth Trends by Region
2.2.1 Global Diabetes Drug Therapy Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Diabetes Drug Therapy Historic Market Size by Region (2018-2023)
2.2.3 Diabetes Drug Therapy Forecasted Market Size by Region (2024-2034)
2.3 Diabetes Drug Therapy Market Dynamics
2.3.1 Diabetes Drug Therapy Industry Trends
2.3.2 Diabetes Drug Therapy Market Drivers
2.3.3 Diabetes Drug Therapy Market Challenges
2.3.4 Diabetes Drug Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Drug Therapy Players by Revenue
3.1.1 Global Top Diabetes Drug Therapy Players by Revenue (2018-2023)
3.1.2 Global Diabetes Drug Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Diabetes Drug Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Drug Therapy Revenue
3.4 Global Diabetes Drug Therapy Market Concentration Ratio
3.4.1 Global Diabetes Drug Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Drug Therapy Revenue in 2024
3.5 Diabetes Drug Therapy Key Players Head office and Area Served
3.6 Key Players Diabetes Drug Therapy Product Solution and Service
3.7 Date of Enter into Diabetes Drug Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Drug Therapy Breakdown Data by Type
4.1 Global Diabetes Drug Therapy Historic Market Size by Type (2018-2023)
4.2 Global Diabetes Drug Therapy Forecasted Market Size by Type (2024-2034)
5 Diabetes Drug Therapy Breakdown Data by Application
5.1 Global Diabetes Drug Therapy Historic Market Size by Application (2018-2023)
5.2 Global Diabetes Drug Therapy Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Diabetes Drug Therapy Market Size (2018-2034)
6.2 North America Diabetes Drug Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Diabetes Drug Therapy Market Size by Country (2018-2023)
6.4 North America Diabetes Drug Therapy Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Drug Therapy Market Size (2018-2034)
7.2 Europe Diabetes Drug Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Diabetes Drug Therapy Market Size by Country (2018-2023)
7.4 Europe Diabetes Drug Therapy Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Drug Therapy Market Size (2018-2034)
8.2 Asia-Pacific Diabetes Drug Therapy Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Diabetes Drug Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Diabetes Drug Therapy Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Drug Therapy Market Size (2018-2034)
9.2 Latin America Diabetes Drug Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Diabetes Drug Therapy Market Size by Country (2018-2023)
9.4 Latin America Diabetes Drug Therapy Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Drug Therapy Market Size (2018-2034)
10.2 Middle East & Africa Diabetes Drug Therapy Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Diabetes Drug Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Diabetes Drug Therapy Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Diabetes Drug Therapy Introduction
11.1.4 Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Mannkind Corporation
11.2.1 Mannkind Corporation Company Detail
11.2.2 Mannkind Corporation Business Overview
11.2.3 Mannkind Corporation Diabetes Drug Therapy Introduction
11.2.4 Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2018-2023)
11.2.5 Mannkind Corporation Recent Development
11.3 Bristol Myers Squibb
11.3.1 Bristol Myers Squibb Company Detail
11.3.2 Bristol Myers Squibb Business Overview
11.3.3 Bristol Myers Squibb Diabetes Drug Therapy Introduction
11.3.4 Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2018-2023)
11.3.5 Bristol Myers Squibb Recent Development
11.4 Medtronic
11.4.1 Medtronic Company Detail
11.4.2 Medtronic Business Overview
11.4.3 Medtronic Diabetes Drug Therapy Introduction
11.4.4 Medtronic Revenue in Diabetes Drug Therapy Business (2018-2023)
11.4.5 Medtronic Recent Development
11.5 AstraZeneca
11.5.1 AstraZeneca Company Detail
11.5.2 AstraZeneca Business Overview
11.5.3 AstraZeneca Diabetes Drug Therapy Introduction
11.5.4 AstraZeneca Revenue in Diabetes Drug Therapy Business (2018-2023)
11.5.5 AstraZeneca Recent Development
11.6 Eli Lilly and Company
11.6.1 Eli Lilly and Company Company Detail
11.6.2 Eli Lilly and Company Business Overview
11.6.3 Eli Lilly and Company Diabetes Drug Therapy Introduction
11.6.4 Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2018-2023)
11.6.5 Eli Lilly and Company Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Diabetes Drug Therapy Introduction
11.7.4 GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
11.8 Sanofi
11.8.1 Sanofi Company Detail
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Diabetes Drug Therapy Introduction
11.8.4 Sanofi Revenue in Diabetes Drug Therapy Business (2018-2023)
11.8.5 Sanofi Recent Development
11.9 Novo Nordisk
11.9.1 Novo Nordisk Company Detail
11.9.2 Novo Nordisk Business Overview
11.9.3 Novo Nordisk Diabetes Drug Therapy Introduction
11.9.4 Novo Nordisk Revenue in Diabetes Drug Therapy Business (2018-2023)
11.9.5 Novo Nordisk Recent Development
11.10 Novartis International AG
11.10.1 Novartis International AG Company Detail
11.10.2 Novartis International AG Business Overview
11.10.3 Novartis International AG Diabetes Drug Therapy Introduction
11.10.4 Novartis International AG Revenue in Diabetes Drug Therapy Business (2018-2023)
11.10.5 Novartis International AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Diabetes Drug Therapy Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Oral
Table 3. Key Players of Subcutaneous
Table 4. Key Players of Intravenous
Table 5. Global Diabetes Drug Therapy Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 6. Global Diabetes Drug Therapy Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 7. Global Diabetes Drug Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global Diabetes Drug Therapy Market Share by Region (2018-2023)
Table 9. Global Diabetes Drug Therapy Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 10. Global Diabetes Drug Therapy Market Share by Region (2024-2034)
Table 11. Diabetes Drug Therapy Market Trends
Table 12. Diabetes Drug Therapy Market Drivers
Table 13. Diabetes Drug Therapy Market Challenges
Table 14. Diabetes Drug Therapy Market Restraints
Table 15. Global Diabetes Drug Therapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global Diabetes Drug Therapy Market Share by Players (2018-2023)
Table 17. Global Top Diabetes Drug Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Drug Therapy as of 2024)
Table 18. Ranking of Global Top Diabetes Drug Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Diabetes Drug Therapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Diabetes Drug Therapy Product Solution and Service
Table 22. Date of Enter into Diabetes Drug Therapy Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Diabetes Drug Therapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global Diabetes Drug Therapy Revenue Market Share by Type (2018-2023)
Table 26. Global Diabetes Drug Therapy Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 27. Global Diabetes Drug Therapy Revenue Market Share by Type (2024-2034)
Table 28. Global Diabetes Drug Therapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global Diabetes Drug Therapy Revenue Market Share by Application (2018-2023)
Table 30. Global Diabetes Drug Therapy Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 31. Global Diabetes Drug Therapy Revenue Market Share by Application (2024-2034)
Table 32. North America Diabetes Drug Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. North America Diabetes Drug Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America Diabetes Drug Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 35. Europe Diabetes Drug Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 36. Europe Diabetes Drug Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe Diabetes Drug Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 38. Asia-Pacific Diabetes Drug Therapy Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 39. Asia-Pacific Diabetes Drug Therapy Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific Diabetes Drug Therapy Market Size by Region (2024-2034) & (US$ Million)
Table 41. Latin America Diabetes Drug Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 42. Latin America Diabetes Drug Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America Diabetes Drug Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 44. Middle East & Africa Diabetes Drug Therapy Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 45. Middle East & Africa Diabetes Drug Therapy Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa Diabetes Drug Therapy Market Size by Country (2024-2034) & (US$ Million)
Table 47. Abbott Laboratories Company Detail
Table 48. Abbott Laboratories Business Overview
Table 49. Abbott Laboratories Diabetes Drug Therapy Product
Table 50. Abbott Laboratories Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 51. Abbott Laboratories Recent Development
Table 52. Mannkind Corporation Company Detail
Table 53. Mannkind Corporation Business Overview
Table 54. Mannkind Corporation Diabetes Drug Therapy Product
Table 55. Mannkind Corporation Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 56. Mannkind Corporation Recent Development
Table 57. Bristol Myers Squibb Company Detail
Table 58. Bristol Myers Squibb Business Overview
Table 59. Bristol Myers Squibb Diabetes Drug Therapy Product
Table 60. Bristol Myers Squibb Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 61. Bristol Myers Squibb Recent Development
Table 62. Medtronic Company Detail
Table 63. Medtronic Business Overview
Table 64. Medtronic Diabetes Drug Therapy Product
Table 65. Medtronic Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 66. Medtronic Recent Development
Table 67. AstraZeneca Company Detail
Table 68. AstraZeneca Business Overview
Table 69. AstraZeneca Diabetes Drug Therapy Product
Table 70. AstraZeneca Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 71. AstraZeneca Recent Development
Table 72. Eli Lilly and Company Company Detail
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Diabetes Drug Therapy Product
Table 75. Eli Lilly and Company Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. GlaxoSmithKline Company Detail
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Diabetes Drug Therapy Product
Table 80. GlaxoSmithKline Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Sanofi Company Detail
Table 83. Sanofi Business Overview
Table 84. Sanofi Diabetes Drug Therapy Product
Table 85. Sanofi Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 86. Sanofi Recent Development
Table 87. Novo Nordisk Company Detail
Table 88. Novo Nordisk Business Overview
Table 89. Novo Nordisk Diabetes Drug Therapy Product
Table 90. Novo Nordisk Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 91. Novo Nordisk Recent Development
Table 92. Novartis International AG Company Detail
Table 93. Novartis International AG Business Overview
Table 94. Novartis International AG Diabetes Drug Therapy Product
Table 95. Novartis International AG Revenue in Diabetes Drug Therapy Business (2018-2023) & (US$ Million)
Table 96. Novartis International AG Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Diabetes Drug Therapy Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Diabetes Drug Therapy Market Share by Type: 2024 VS 2034
Figure 3. Oral Features
Figure 4. Subcutaneous Features
Figure 5. Intravenous Features
Figure 6. Global Diabetes Drug Therapy Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Diabetes Drug Therapy Market Share by Application: 2024 VS 2034
Figure 8. Online Pharmacies Case Studies
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Diabetes Drug Therapy Report Years Considered
Figure 12. Global Diabetes Drug Therapy Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Diabetes Drug Therapy Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 14. Global Diabetes Drug Therapy Market Share by Region: 2024 VS 2034
Figure 15. Global Diabetes Drug Therapy Market Share by Players in 2024
Figure 16. Global Top Diabetes Drug Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Diabetes Drug Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Diabetes Drug Therapy Revenue in 2024
Figure 18. North America Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Diabetes Drug Therapy Market Share by Country (2018-2034)
Figure 20. United States Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 21. Canada Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Europe Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Diabetes Drug Therapy Market Share by Country (2018-2034)
Figure 24. Germany Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 25. France Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. U.K. Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. Italy Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Russia Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Nordic Countries Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Asia-Pacific Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Diabetes Drug Therapy Market Share by Region (2018-2034)
Figure 32. China Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Japan Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. South Korea Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Southeast Asia Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. India Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Australia Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Latin America Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Diabetes Drug Therapy Market Share by Country (2018-2034)
Figure 40. Mexico Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. Brazil Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Middle East & Africa Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Diabetes Drug Therapy Market Share by Country (2018-2034)
Figure 44. Turkey Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Saudi Arabia Diabetes Drug Therapy Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Abbott Laboratories Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 47. Mannkind Corporation Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 48. Bristol Myers Squibb Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 49. Medtronic Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 50. AstraZeneca Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 51. Eli Lilly and Company Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 52. GlaxoSmithKline Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 53. Sanofi Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 54. Novo Nordisk Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 55. Novartis International AG Revenue Growth Rate in Diabetes Drug Therapy Business (2018-2023)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries